Grants and contracts awarded to Yale School of Medicine

Federal

• Walter Boron, NIH, Physiology of Electrogenetic Na/HCO₃ Cotransporters, 5 years, $1,900,958
  
• Junjie Chen, NIH, Study the Role of Chfr in Tumorigenesis, 4.5 years, $1,427,343
  
• Wonsun Han, NIH, Regulation of Na,K-ATPase Distribution and Function by Arrestin and Spinophilin, 2 years, $94,772
  
• Jonathan Kagan, NIH, Cellular and Molecular Aspects of Toll-Like Receptor Signal Transduction, 1 year, $89,996
  
• Chun Geun Lee, NIH, Genetic Factors Controlling Effector Function of TGF-Beta in COPD and Fibrosis, 5 years, $2,066,770
  
• Daeyeol Lee, NIH, Dynamics of Cortical Communication, 1.5 years, $262,321
  
• Michael Nitabach, NIH, Calcium Signaling in Circadian Clock Neurons, 4 months, $386,500
  
• Harvey Risch, NIH, Case-Control Study of Pancreas Cancer in Shanghai, China, 5 years, $3,596,491
  
• Bing Su, NIH, Regulation and Function of MEKK3 in Dendritic Cells, 1 year, $349,191; NIH, Molecular Mechanisms of MEKK3, 1.5 years, $143,759
  
• Patrick Sung, NIH, Molecular Basis of BRCA2-Mediated DNA Repair and Cancer Avoidance, 5 years, $1,841,689
  
• Terrence Town, NIH, Blocking TGF-Beta Immune Signaling as a Therapeutic Target for Alzheimer’s Disease, 1 year, $90,000
  
• Anthony Van den Pol, NIH, Hypocretin Neurons, 4 years, $1,447,487

Non-Federal

• Zane Andrews, Foundation for Research Science & Technology, Molecular and Neuroanatomical Mechanisms of Ghrelin Signaling in the Brain: Implications for Obesity, 1 year, $58,464
  
• Aydin Arici, Serono, Inc. (U.S.A.), The Role of AKT Signaling Pathway in the Pathogenesis of Endometriosis, 2 years, $56,824
  
• Xueying Chen, American Heart Assoc. (Heritage Affiliate), Computational Screening for Dosage-Sensitive Genes Involved in Cardiovascular Diseases, 1 year, $18,334
  
• Robert Constable, Pfizer, Inc., A Study to Investigate the Utility of Magnetic Resonance Endpoints for Defining Liver Disease in Subjects with Chronic HCV, 1 year, $195,568
  
• Karen Dorsey, St. Luke’s-Roosevelt Institute for Health Sciences, Metabolic Effects of Differential Organ Growth Rates, 6 months, $151,411
  
• Marie Egan, Cystic Fibrosis Foundation, Cystic Fibrosis Clinical Research Facilitation Awards, 1 year, $64,800
  
• Gerald Friedland, Institute for Clinical Research Inc., International Network for Strategic Initiatives in Global HIV Trials, 4.5 years, $513,621
  
• Bryan Hains, American Pain Society, Supraspinal Modulation of Pain after SCI by Microglia, 1 year, $20,000
  
• Kevan Herold, Juvenile Diabetes Research Foundation Int’l, Phase II Trial of hOKT3yl, 1 year, $82,537
  
• Fenghua Hu, Paralyzed Veterans of America, Mechanisms of Amino-Nogo Inhibition, 2 years, $100,000
  
• Henry Huang, GlaxoSmithKline Research & Development, Ltd., Evaluation of the PET Ligands [¹¹C]GSK81352 and [¹¹C]PHNO to Image Dopamine D3 Receptor in Rhesus Monkey, 9 months, $210,495; GlaxoSmithKline Research & Development, Ltd., Development of [¹¹C]/[¹⁸F]AFM for First-in-Human Trial of the Serotonin Transporter Ligand AFM, 1 year, $50,000
  
• Ivana Kawikova, Nat’l Alliance for Autism Research, Is Autoimmunity Involved in Pathogenesis of Autism? 2 years, $120,000
  
• John Krystal, Nat’l Alliance for Research on Schizophrenia and Depression, GABRA2 Modulation of NMDA Receptor Deficit-Related PFC Dysfunction, 1 year, $100,000
  
• Daeyeol Lee, University of Rochester, Neural Interactions Among Multiple Motor Structures, 3.5 years, $922,312
  
• Aliza Leiser, Ovarian Cancer Research Fund, Inc. (The), Clinical Implications of the TLR-4/MYD88 Pathway in Epithelial Ovarian Cancer, 2 years, $75,000
  
• Yorgo Modis, Roche Organ Transplantation Foundation, The Structural Basis of Innate Immune Sensing and Signaling by Toll-Like Receptors, 3 years, $242,484
  
• Mary Schwab-Stone, Leon Lowenstein Foundation, Inc., Greenwich Needs Assessment, 1 year, $25,000
  
• Patrick Sung, Lawrence Berkeley Nat’l Laboratories, Modulation of the Functionality of Homologous Recombinational Repair, 9 months, $120,649
  
• James Tsai, Synabridge Corporation, Instrument for Glaucoma Early Detection and Monitoring, 1.5 years, $102,881
  
• Carol Weitzman, Robert Wood Johnson Foundation, Identifying and Treating Maternal Depression in Underserved, Minority Women in a Pediatric Primary Care Setting, 2 years, $202,976
  
• Sandra Wolin, Ellison Medical Foundation, Investigating the Role of Oxidative RNA Damage in Aging, 4 years, $991,688
  
• Yong Xiong, Richard & Susan Smith Family Foundation, Mechanisms of HIV Suppression by Human Antiviral Protein APOBEC3 and HIV’s Countermeasures, 2 years, $200,000